Non-invasive biomarkers of Fontan-associated liver disease

Goldberg, 2017, Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study, J Am Heart Assoc, 6 Roeleveld, 2018, Hypoplastic left heart syndrome: from fetus to Fontan, Cardiol Young, 28, 1275, 10.1017/S104795111800135X Gordon-Walker, 2019, Fontan-associated liver disease: a review, J Cardiol, 74, 223 Emamaullee, 2020, Fontan-associated liver disease: screening, management, and transplant considerations, Circulation, 142, 591, 10.1161/CIRCULATIONAHA.120.045597 Surrey, 2016, Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation, Hum Pathol, 57, 106, 10.1016/j.humpath.2016.07.006 Rychik, 2012, The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium, Pediatr Cardiol, 33, 1001, 10.1007/s00246-012-0315-7 Wu, 2015, Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes, J Heart Lung Transplant, 34, 883, 10.1016/j.healun.2015.01.993 Munsterman, 2019, The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort, Eur Heart J, 40, 1057, 10.1093/eurheartj/ehy620 Evans, 2020, The rate of hepatic fibrosis progression in patients post-Fontan, Pediatr Cardiol, 41, 905, 10.1007/s00246-020-02331-0 Patel, 2020, Routine surveillance catheterization is useful in guiding management of stable Fontan patients, Pediatr Cardiol, 41, 624, 10.1007/s00246-020-02293-3 Atz, 2017, Longitudinal outcomes of patients with single ventricle after the Fontan procedure, J Am Coll Cardiol, 69, 2735, 10.1016/j.jacc.2017.03.582 Allen, 2014, Review article: the management of cirrhosis in women, Aliment Pharmacol Ther, 40, 1146, 10.1111/apt.12974 Lau-Corona, 2011, The impact of genetic variability on liver disease in the Hispanic/Latin-American population, Autoimmunity, 44, 549, 10.3109/08916934.2011.592883 Streba, 2015, Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question, World J Gastroenterol, 21, 4103, 10.3748/wjg.v21.i14.4103 Greenway, 2016, Fontan-associated liver disease: implications for heart transplantation, J Heart Lung Transplant, 35, 26, 10.1016/j.healun.2015.10.015 Schwartz, 2009, Measurement and estimation of GFR in children and adolescents, Clin J Am Soc Nephrol, 4, 1832, 10.2215/CJN.01640309 Heuman, 2007, MELD-XI: a rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy, Liver Transpl, 13, 30, 10.1002/lt.20906 Peng, 2016, Child–Pugh versus MELD score for the assessment of prognosis in liver cirrhosis, Medicine (Baltimore), 95, e2877, 10.1097/MD.0000000000002877 Barshes, 2006, The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients, Liver Transpl, 12, 475, 10.1002/lt.20703 Wai, 2003, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, 38, 518, 10.1053/jhep.2003.50346 Vallet-Pichard, 2007, FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest, Hepatology, 46, 32, 10.1002/hep.21669 Dindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097/01.sla.0000133083.54934.ae Bosch, 2019, Validation of a congestive hepatic fibrosis scoring system, Am J Surg Pathol, 43, 766, 10.1097/PAS.0000000000001250 Evans, 2016, MELD-XI scores correlate with post-Fontan hepatic biopsy fibrosis scores, Pediatr Cardiol, 37, 1274, 10.1007/s00246-016-1428-1 Lin, 2011, Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis, Hepatology, 53, 726, 10.1002/hep.24105 Li, 2014, The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis, PLoS One, 9 Kiesewetter, 2007, Hepatic changes in the failing Fontan circulation, Heart, 93, 579, 10.1136/hrt.2006.094516 Kendall, 2008, Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study, J Clin Pathol, 61, 504, 10.1136/jcp.2007.052365 Ghaferi, 2005, Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma, J Thorac Cardiovasc Surg, 129, 1348, 10.1016/j.jtcvs.2004.10.005 Silva-Sepulveda, 2019, Evaluation of Fontan liver disease: correlation of transjugular liver biopsy with magnetic resonance and hemodynamics, Congenit Heart Dis, 14, 600, 10.1111/chd.12770 Di Maria, 2019, Surveillance testing and preventive care after Fontan operation: a multi-institutional survey, Pediatr Cardiol, 40, 110, 10.1007/s00246-018-1966-9 Rodriguez, 2021, Pretransplantation and post-transplantation liver disease assessment in adolescents undergoing isolated heart transplantation for Fontan failure, J Pediatr, 229, P78, 10.1016/j.jpeds.2020.09.044 Menteer, 2021, Immunologic and survival benefits of combined heart-liver transplantation in children, Transplantation, 105, e107, 10.1097/TP.0000000000003810 Keung, 2020, Fontan-associated liver disease: pathophysiology, investigations, predictors of severity and management, Eur J Gastroenterol Hepatol, 907, 10.1097/MEG.0000000000001641 Azer, 1996, Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease, J Gastroenterol Hepatol, 11, 208, 10.1111/j.1440-1746.1996.tb00064.x An, 2020, Early development of hepatic fibrosis after Fontan procedure: a non-invasive study of a subclinical liver disease, Int J Cardiol, 320, 64, 10.1016/j.ijcard.2020.08.009 Chou, 2013, Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review, Ann Intern Med, 158, 807, 10.7326/0003-4819-158-11-201306040-00005 Afdhal, 2008, Thrombocytopenia associated with chronic liver disease, J Hepatol, 48, 1000, 10.1016/j.jhep.2008.03.009 Schwimmer, 2006, Prevalence of fatty liver in children and adolescents, Pediatrics, 118, 1388, 10.1542/peds.2006-1212 Estes, 2018, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, 67, 123, 10.1002/hep.29466 Karamlou, 2018, Resolving the Fontan paradox: addressing socioeconomic and racial disparities in patients with a single ventricle, J Thorac Cardiovasc Surg, 155, 1727, 10.1016/j.jtcvs.2017.11.103 Martinez, 2016, Increased body mass index is associated with congestive heart failure and mortality in adult Fontan patients, Congenit Heart Dis, 11, 71, 10.1111/chd.12296 Simon, 2019, Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 17, 2776, 10.1016/j.cgh.2019.04.061 Poujol-Robert, 2014, Aspirin may reduce liver fibrosis progression: evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation, Clin Res Hepatol Gastroenterol, 38, 570, 10.1016/j.clinre.2014.07.004 Jiang, 2016, Aspirin use is associated with lower indices of liver fibrosis among adults in the United States, Aliment Pharmacol Ther, 43, 734, 10.1111/apt.13515 Iqbal, 2019, Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis, Hepatol Int, 13, 84, 10.1007/s12072-018-9918-2 Vaikunth, 2020, Does liver biopsy accurately measure fibrosis in Fontan-associated liver disease? A comparison of liver biopsy pre–combined heart and liver transplant and liver explant post-transplant, Clin Transplant, 34, 10.1111/ctr.14120